All guides
SARMs

SARMs: human data and mislabelling studies

A closer look at what has been studied in people and what analytical surveys have found when testing products sold as SARMs.

01

Human data are compound-specific

Trials and published human observations exist for some SARM candidates, but development status and evidence quality differ. Findings for one candidate should not be applied to every product sold under the SARM label.

02

Market surveys ask a different question

Analytical surveys examine whether purchased products contain the labelled compound and quantity. Their findings describe sampled products at a point in time, not every seller or every future batch.

03

Use exact identities and aliases

Marketing names, development codes and informal abbreviations can overlap or be used inconsistently. A reliable record maps aliases to the precise claimed molecule and retains the wording shown on the original listing.

Next guideA map of performance-enhancing compounds